Vijayasimha, M

About

I am Dr. Mulavagili Vijayasimha, Professor in the Department of Medical Laboratory Technology at Chandigarh University, India. With more than 20 years of academic and research experience, I have served in leading universities including Jaipur National University, Amity University, Rishihood University, Neotia University, CT University, and Malla Reddy University.

I hold an M.Sc. in Biochemistry, an M.Sc. in Medical Laboratory Technology, and a Ph.D. in Biochemistry. My teaching expertise spans Clinical Biochemistry, Enzymes, Vitamins, Medical Laboratory Techniques, Hematology, Immunology, and related fields at both undergraduate and postgraduate levels. I have also supervised Ph.D. and M.Sc. dissertations.

My research focuses on clinical biochemistry, enzymology, and novel diagnostic markers for acute kidney injury and other metabolic disorders. I have published extensively in national and international journals, contributed book chapters, and filed multiple patents.

I am actively engaged in academic leadership, having served as Head of Department, Board of Studies (BOS) member at several universities, and advisor to laboratories and institutions. I am also a permanent member of professional associations including the All India Medical Laboratory Technologists Association, Association of Clinical Biochemists of India, and the International Society for Development and Sustainability.

Alongside my academic journey, I have contributed as a reviewer, textbook author, and speaker at conferences and workshops, with a passion for advancing Allied Health Sciences education and research in India.

Employment

• Chandigarh University Professor
  2025 - Present
• Rishihood University H O D
  2021 - 2023

Education

• Acharya Nagarjuna University PhD
  2010 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (107)

• Equity-aware variant interpretation needs local allele frequencies and calibrated functional evidence: comment on Bianco & Planello (2025)
  Molecular Genetics and Genomics 2026 DOI: 10.1007/s00438-025-02343-6
  +Save
• From diagnostic accuracy to antibiotic actionability: An equity-ready standard for point-of-care urinary tract infection testing
  Diagnostic Microbiology and Infectious Disease 2026 DOI: 10.1016/j.diagmicrobio.2026.117615
  +Save
• From mechanism to implementable benefit: decision-grade inflammasome modulation for Salmonella control
  Molecular Biology Reports 2026 DOI: 10.1007/s11033-026-11638-9
  +Save
• Re: Impact of digital versus faxed e-referrals on triage decisions in a medical retina clinic
  Clinical and Experimental Optometry 2026 DOI: 10.1080/08164622.2026.2654959
  +Save
• From JAK2 degradation to precision immunotherapy: A translational passport for strebloside in Epstein–Barr virus-associated gastric cancer
  Translational Research 2026 DOI: 10.1016/j.trsl.2026.07.011
  +Save
• Beyond “ORT-positive”: Why genomic divergence in Ornithobacterium should reshape poultry diagnostics, surveillance, and vaccine strategy
  Veterinary Microbiology 2026 DOI: 10.1016/j.vetmic.2026.111148
  +Save
• Comment on: Evaluating large language models vs residents in cataract and refractive surgery: comparative analysis using the American Academy of Ophthalmology Self-Assessment Program
  Journal of Cataract & Refractive Surgery 2026 DOI: 10.1097/j.jcrs.0000000000001999
  +Save
• When reporter positivity is not lineage identity: A four-gate validation framework for stress-exposed Cre-loxP histochemistry
  Acta Histochemica 2026 DOI: 10.1016/j.acthis.2026.152358
  +Save
• From Hypothesis-generating to Decision-grade: Making Finerenone–spironolactone Comparisons in HFpEF Globally Implementable
  Cardiovascular Drugs and Therapy 2026 DOI: 10.1007/s10557-026-07856-9
  +Save
• From Single-cell Heterogeneity to Regenerative-medicine Accountability: A Global Readiness Passport for Stem-Cell Products
  Stem Cell Reviews and Reports 2026 DOI: 10.1007/s12015-026-11178-6
  +Save